Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01499121
Title Study of Efficacy and Safety of Sunitinib Given on an Individualized Schedule
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sunnybrook Health Sciences Centre
Indications

clear cell renal cell carcinoma

Therapies

Sunitinib

Age Groups: adult
Covered Countries CAN


No variant requirements are available.